Literature DB >> 31393619

The protective effects of L-carnitine on myocardial ischaemia-reperfusion injury in patients with rheumatic valvular heart disease undergoing CPB surgery are associated with the suppression of NF-κB pathway and the activation of Nrf2 pathway.

Ming Li1, Suochun Xu1, Yan Geng2, Lei Sun3, Ruili Wang4, Yang Yan1, Haichen Wang1, Yongxin Li1, Qiuyue Yi1, Yongjian Zhang1, Junjun Hao1, Chao Deng1, Wen Li2, Li Xue2.   

Abstract

Myocardial ischaemia-reperfusion injury (MIRI) is a main pathophysiologic change following CPB surgery. L-carnitine, a natural amino acid, is able to transport fatty acids for generating energy and has a protective effect on MIRI. We aim to investigate the protective effect of L-carnitine on MIRI in patients with rheumatic valvular heart disease (RVHD) performed CPB surgical operation and the underlying mechanism. In this study, patients were randomized to three groups. L-carnitine was added to the crystalloid cardioplegic solution for experimental group 1 (6 g/L) and experimental group 2 (12 g/L), whereas no L-carnitine was used in the control group. Our results showed that L-carnitine significantly attenuated myocardial injury after surgery in these patients. L-carnitine decreased serum markers of myocardial injury including CK-MB, cTnI, hs-cTnT and IMA. L-carnitine increased left ventricular ejection fraction (LVEF) but reduced wall motion score index (WMSI) after operation. L-carnitine also inhibited myeloperoxidase (MPO) activity and inflammatory cytokines in the myocardium of patients after unclamping the aorta. Additionally, L-carnitine increased levels of superoxide dismutase (SOD) and catalase (CAT) while decreased levels of malondialdehyde (MDA) and protein carbonyl content in the myocardium of patients after unclamping the aorta. Moreover, L-carnitine suppressed the activation of nuclear factor kappa B (NF-κB) and activated nuclear factor erythroid 2-related factor 2 (Nrf2). There was also no significant difference in these indices between two experimental groups after unclamping the aorta. Taken together, L-carnitine had a protective effect against CPB-induced MIRI in patients with RVHD, which might be related to its modulation of NF-κB and Nrf2 activities.
© 2019 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  L-carnitine; cardiopulmonary bypass surgery; myocardial ischaemia-reperfusion injury; oxidative stress; rheumatic valvular heart disease

Mesh:

Substances:

Year:  2019        PMID: 31393619     DOI: 10.1111/1440-1681.13155

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  6 in total

1.  Sevoflurane alleviates myocardial ischemia/reperfusion injury via actitation of heat shock protein-70 in patients undergoing double valve replacement surgery.

Authors:  Yue Shan; Kai Xie; Qifu Zhou; Rui He; Zhonghua Chen; Weizhong Feng
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

2.  L-Carnitine Reduces Myocardial Oxidative Stress and Alleviates Myocardial Ischemia-Reperfusion Injury by Activating Nuclear Transcription-Related Factor 2 (Nrf2)/Heme Oxygenase-1 (HO-1) Signaling Pathway.

Authors:  Tana Zhao; Shangjun Chen; Bingxin Wang; Dongliang Cai
Journal:  Med Sci Monit       Date:  2020-05-26

3.  Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy.

Authors:  Mingming Zhao; Haoran Wei; Chenze Li; Rui Zhan; Changjie Liu; Jianing Gao; Yaodong Yi; Xiao Cui; Wenxin Shan; Liang Ji; Bing Pan; Si Cheng; Moshi Song; Haipeng Sun; Huidi Jiang; Jun Cai; Minerva T Garcia-Barrio; Y Eugene Chen; Xiangbao Meng; Erdan Dong; Dao Wen Wang; Lemin Zheng
Journal:  Nat Commun       Date:  2022-04-01       Impact factor: 17.694

Review 4.  Contribution of Oxidative Stress (OS) in Calcific Aortic Valve Disease (CAVD): From Pathophysiology to Therapeutic Targets.

Authors:  Daniela Maria Tanase; Emilia Valasciuc; Evelina Maria Gosav; Mariana Floria; Claudia Florida Costea; Nicoleta Dima; Ionut Tudorancea; Minela Aida Maranduca; Ionela Lacramioara Serban
Journal:  Cells       Date:  2022-08-27       Impact factor: 7.666

Review 5.  Role of Nrf2 and Its Activators in Cardiocerebral Vascular Disease.

Authors:  Liangkai Cheng; Hong Zhang; Fang Wu; Zhongqiu Liu; Yuanyuan Cheng; Caiyan Wang
Journal:  Oxid Med Cell Longev       Date:  2020-08-05       Impact factor: 6.543

6.  Interference with the expression of S1PR1 or STAT3 attenuates valvular damage due to rheumatic heart disease.

Authors:  Shenglin Xian; Ang Chen; Yunjiao Wu; Hong Wen; Chuanghong Lu; Feng Huang; Zhiyu Zeng
Journal:  Int J Mol Med       Date:  2021-07-23       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.